Catalent Pharma Solutions has completed the expansion of its warehousing facilities in Schorndorf, Germany for its Clinical Supply Services business. This increased capacity for the storage and distribution of Investigational Medicinal Products (IMPs) includes dedicated storage for controlled, highly potent or cytotoxic drugs.
 
The expansion follows the acquisition of Aptuit’s Clinical Trial Supplies business earlier this year.  Peter Brun, director, Clinical Supply Services, said, “The additional GMP storage capacity enhances Catalent’s ability to support customers’ global development and multi-center clinical studies. Our Schorndorf facility’s central European location is convenient to serve a wide area and assures customers of reliable supply throughout their development programs and on to commercial supply.”